Updates are available Correction dated 2022-06-02
Click to view Correction: https://doi.org/10.1007/s00228-022-03342-x
-
Authors
Wurmbach, Viktoria S.
Schmidt, Steffen J.
Lampert, Anette
Bernard, Simone
Meid, Andreas D.
Frick, Eduard
Metzner, Michael
Wilm, Stefan
Mortsiefer, Achim
Bücker, Bettina
Altiner, Attila
Sparenberg, Lisa
Szecsenyi, Joachim
Peters-Klimm, Frank
Kaufmann-Kolle, Petra
Thürmann, Petra A.
Haefeli, Walter E.
Seidling, Hanna M. http://orcid.org/0000-0002-1215-634X
-
Funding
Funding for this research was provided by:
Innovation Fund of The Federal Joint Committee (01VSF16019)
Ruprecht-Karls-Universität Heidelberg
- License Information
-
More Information
Article History
Received: 14 December 2021
Accepted: 14 March 2022
First Online: 27 April 2022
Change Date: 2 June 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00228-022-03342-x
Declarations
:
: The study HIOPP-6 was approved by the ethics committees of the Medical Faculty of Heidelberg (S-672/2017), the University of Witten/Herdecke (57/2018), the Medical Faculty of Heinrich Heine University Düsseldorf (2018–41-Zweitvotum), the Medical Faculty of University of Rostock (B-F-2018–016), and the Medical Association of Baden Württemberg (A2018-0036).
: Written informed consent was obtained from all individual participants included in the study.
: Not applicable.
: Petra A. Thürmann and Walter E. Haefeli are advisory editors of the European Journal of Clinical Pharmacology. In addition, Petra Kaufmann-Kolle reports grants from the Federal Ministry of Health and Joachim Szecsenyi reports to hold stock of the aQua Institute, during the conduct of the study. The authors report no further conflicts of interest regarding this work.
